Pasar al contenido principal
Premio 2024 - Mejor Publicación en el Área de Materno-Infantil y del Adolescente

Maria Dolores Fernandez-Garcia 1 2Nerea Garcia-Ibañez 1Juan Camacho 1Almudena Gutierrez 3 4Laura Sánchez García 3 4Cristina Calvo 3 4 5Antonio Moreno-Docón 6Ana Isabel Menasalvas 6Antonio Medina 7Mercedes Perez-Ruiz 7Maria Carmen Nieto Toboso 8Carmen Muñoz-Almagro 9 2 10Cristian Launes 2 10Carla Berengua 11María Cabrerizo 1 2 4Spanish study group for Enterovirus and Parechovirus infections (PI22CIII-00035) 12Spanish study group for Enterovirus and Parechovirus infections

Collaborators, Affiliations Expand

Abstract

BackgroundIn 2023, a European alert was issued regarding an increase in severe enterovirus (EV) neonatal infections associated with echovirus 11 (E11) new lineage 1.AimTo analyse E11-positive cases between 2019 and 2023 to investigate whether the new lineage 1 circulated in Spain causing severe neonatal infections.MethodsEV-positive samples from hospitalised cases are sent for typing to the National Reference Enterovirus Laboratory. Available samples from 2022-23 were subjected to metagenomic next-generation sequencing.ResultsOf 1,288 samples genotyped, 103 were E11-positive (98 patients: 6 adults, 33 neonates, 89 children under 6 years; male to female ratio 1.9). E11 detection rate was similar before and after detection of the new lineage 1 in Spain in June 2022 (9.7% in 2019 vs 10.6% in 2023). The proportion of E11-infected ICU-admitted neonates in 2019-2022 (2/7) vs 2022-2023 (5/12) did not significantly differ (p = 0.65). In severe neonatal infections, 4/7 E11 strains were not linked to the new lineage 1. The three novel E11 recombinant genomes were associated with severe (n = 2) and non-severe (n = 1) cases from 2022-2023 and clustered outside the new lineage 1. Coinfecting pathogenic viruses were present in four of 10 E11-positive samples.ConclusionThe emergence of the new lineage 1 is not linked with an increase in incidence or severity of neonatal E11 infections in Spain. The detection of two novel E11 recombinants associated with severe disease warrants enhancing genomic and clinical surveillance.

Keywords: Enterovirus; echovirus 11; genomic surveillance; international alert; neonatal infection; new variant; recombinant.